MedPath

Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform for Improving CPAP Compliance in Low Cardiovascular Risk Sleep Apnea Patients : OPTISAS 1 Study

Phase 4
Conditions
Sleep Apnea Syndrome
Low Cardiovascular Risk
Interventions
Device: Continuous Positive Airway Pressure (CPAP) in sleep apnea patients
Registration Number
NCT01796769
Lead Sponsor
Fédération Française de Pneumologie
Brief Summary

Targeted population:

Sleep apnea patients at low cardiovascular risk newly treated by CPAP

Hypothesis:

Six months CPAP compliance might be greater in the telemonitoring arm compared to usual CPAP care.

Main goal:

To compare 6-months CPAP compliance when Sleep Apnea patients at low cardiovascular risk are randomly allocated to usual CPAP care or a multidisciplinary and coordinated follow-up based on a telemonitoring web platform.

Detailed Description

Study procedures:

The telemonitoring system will involve respiratory physicians, home care providers and include regular assessments of oximetry, CPAP compliance, side effects and residual events.

Secured data transmission to medical staff computers and secured websites will allow easy telemonitoring. Automatic algorithms have been built-up for early adjustment of CPAP treatment in case of side effects, leaks and persistent residual events.

An interim analysis will be performed when 200 patients will be included.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
936
Inclusion Criteria
  • Age between 18 to 78 years
  • Men and women
  • AHI > 30 / hour
  • Patient with low cardiovascular score (<5% defined by European SCORE)
  • Patient affiliated to the national health insurance
  • Willingness to use a telemonitoring system
Exclusion Criteria
  • Known cardiovascular disease (i.e. transient ischemic attack, stroke, coronary artery disease)
  • Central sleep apnea syndrome
  • Previous CPAP treatment with respiratory support for sleep respiratory trouble
  • Cardiac failure
  • Hypercapnic chronic respiratory failure (daytime PaCO2 > 50 mmHg)
  • Terminal disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ConventionalContinuous Positive Airway Pressure (CPAP) in sleep apnea patients-
TelemedicineContinuous Positive Airway Pressure (CPAP) in sleep apnea patients-
Primary Outcome Measures
NameTimeMethod
Change from baseline CPAP compliance at 6 monthsday 0 and month 6

CPAP compliance evolution by comparing baseline and 6 months measurements. CPAP compliance is assessed at month 6 in the two groups.

Secondary Outcome Measures
NameTimeMethod
Subjective Sleepinessinclusion and month 6

Sleepiness is assessed with Epworth Sleepiness Scale at inclusion and month 6 in the two groups

Quality of Lifeinclusion and month 6

Quality of life is assessed with SF-12 questionnaire at inclusion and month 6 in the two groups

Cost analysismonth 6

Cost analysis will include all key resources associated with the telemonitoring intervention and related health (referrals, consultations, resource use)

Fatigueinclusion and month 6

Fatigue is assessed with Pichot Scale at inclusion and month 6 in the two groups

Health statusinclusion and month 6

Health status is assessed with EQ-5D questionnaire at inclusion and month 6 in the two groups

Trial Locations

Locations (12)

Hospital Nord Ouest

🇫🇷

Villefranche Sur Saone, France

Dieulefit Santé Clinic

🇫🇷

Dieulefit, France

Tessier Clinic

🇫🇷

Valenciennes, France

Saint Vincent Clinic

🇫🇷

Epernay, France

La Louvière Clinic

🇫🇷

Lille, France

University Hospital

🇫🇷

Rouen, France

University Hospital Calmette

🇫🇷

Lille, France

General Hospital

🇫🇷

St Avold, France

Ambroise Paré Hospital

🇫🇷

Marseille, France

Les Rieux Clinic

🇫🇷

Nyons, France

Hospital Bichat Claude Bernard

🇫🇷

Paris, France

Respiratory physician in private practice

🇫🇷

Valence, France

© Copyright 2025. All Rights Reserved by MedPath